Lowan Stewart

Dr. Stewart is a specialist Emergency Physician, practicing since 2003 in the US and in Norway. He was a cofounder of Insight Ketamine in 2016, Axon Clinic in 2018, and the first public ketamine treatment unit in Scandinavia at Sykehuset Østfold in 2020. He is a medical consultant for PsykForsk, working on clinical trials with psilocybin, MDMA and ketamine and an advisor to the public ketamine units. He was the Regional Director for Awakn, and is currently the medical Director of Axon Clinics. He is a founding member of the national research group Norwegian Rapid-Acting Antidepressant Network (NORAAD), the psychedelic research group at the University of Oslo and the Eating Disorder Lab at Oslo Nye Høyskole. Dr. Stewart is the co-founder of the Norwegian Association for Psychedelic Science, an Expert Faculty Member of the American Society of Ketamine Physicians and serves as associate editor for the Journal of Psychedelic Studies.